COMPANY PROFILE

PhaseV

Uses advanced algorithms to optimize clinical trials, improving success rates, efficiency, and uncovering hidden signals in the data

Tel Aviv-Yafo, IsraelFounded 2023Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Revenue $1–10M Latest reported FY

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About PhaseV

PhaseVTrials.com is a cutting-edge startup that specializes in developing a platform for adaptive clinical trial design and execution. The company leverages advanced technologies such as reinforcement learning and causal machine learning (ML) to optimize clinical decisions at any stage of the trial process. Their platform features an intuitive user interface and a flexible software architecture, making it accessible and adaptable for various clinical needs.

Read full description

PhaseVTrials primarily serves pharmaceutical companies, biotech firms, and research institutions that are involved in drug development and clinical research. The market it operates in is the clinical trials sector, which is a critical component of the broader healthcare and pharmaceutical industries.

The business model of PhaseVTrials revolves around providing a software-as-a-service (SaaS) platform. Clients subscribe to their platform to design, manage, and execute clinical trials more efficiently. The company generates revenue through subscription fees, which can be tiered based on the level of service and features required by the client. Additionally, they may offer consulting services to help clients optimize their trial designs and execution strategies.

PhaseVTrials stands out in the market by offering a unique combination of advanced algorithms and user-friendly software. This allows clients to make data-driven decisions, potentially reducing the time and cost associated with bringing new drugs to market. The platform's ability to adapt and provide real-time insights is particularly valuable in the fast-paced and highly regulated environment of clinical trials.

In summary, PhaseVTrials.com is revolutionizing the clinical trial process with its adaptive design and execution platform, serving pharmaceutical and biotech companies with a SaaS business model that leverages advanced algorithms for optimal decision-making.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2023
Headquarters: Tel Aviv-Yafo, Israel
Employees: 63
Open positions: 7
Dealroom signal: 92.9/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Oncology, Core AI, Clinical Trials, Tech for Biotech and Pharma, Tech for Hospitals and Clinics, Biotech and Pharma
Technology: Artificial Intelligence, Machine Learning
Business model: SaaS
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

2 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES AOther financing	May 2025	$50M	$200M	LionBird · Exor Ventures · Insight Partners · Viola Ventures	↗
EARLY VCOther financing	Oct 2023	$15M	$60M	LionBird · Viola Ventures · Exor Ventures	↗

Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth
2026
2025
2024
2023		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

PhaseV website traffic

Latest recorded traffic for PhaseV is 7.9K monthly website visits, down 28.2% over the last three months. PhaseV's team grew 23.5% over the past year.

Latest monthly visits7.9K 3-month web change-28.2% 1-year team growth+23.5%

Monthly website visitsJun 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

QA EngineerTel Aviv-Yafo, Tel Aviv District, Israel · Other · Sep 3, 2026 Legal & Business Operations DirectorBoston, Massachusetts, United States, Northern America, Americas · Legal · Jul 30, 2026 Legal & Business Operations DirectorCambridge, MA · Legal · Jul 24, 2026 Operations ManagerBoston, Massachusetts, United States, Northern America, Americas · Business Development · Jul 23, 2026 Operations ManagerCambridge, MA · Business Development · Jul 22, 2026 Applied AI EngineerTel Aviv-Yafo, Tel Aviv Subdistrict, Tel Aviv District, Israel · Data Science & Engineering · Jan 22, 2026 Financial ControllerCambridge, Massachusetts, United States · Finance · Jan 9, 2026

7 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CTCeleris TherapeuticsPredicting biomolecular interactions and designing drugs for incurable diseases	Graz, Austria	Operational	1	$7.8M	$17M
BIBioXplorDeveloping a computational network pharmacology platform to match optimal drug combinations to the right patients	Dublin, Ireland	Operational
PEPepticomAn Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets	Jerusalem, Israel	Operational
EXExogeneBiotechnology company accelerating target and TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening	Oxford, United Kingdom	Operational
CACastorA cloud-based clinical data platform that simplifies the clinical trial process	New York City, United States	Operational
OBOchre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally	Oxford, United Kingdom	Operational
R(Research Grid (R.grid)AI-powered automation engine for admin-free clinical trials	Norwich, United Kingdom	Operational
TATurbine AISimulation-driven drug discovery company delivering population targeted cancer therapies	Budapest, Hungary	Operational